Core Laboratories（纽交所代码：CLB）宣布将于2026年7月30日美国中部夏令时7:30/美国东部夏令时8:30举办2026年第二季度投资者及分析师电话会议。 公司将于2026年7月29日股市收盘后发布第二季度财报新闻稿，公众可通过官网www.corelab.com/investors查阅。本次会议将由公司董事长兼首席执行官拉里·布鲁诺、首席财务官克里斯·希尔、企业发展与投资者关 ...

Core Laboratories（纽交所代码：CLB）宣布将于2026年7月30日美国中部夏令时7:30/美国东部夏令时8:30召开2026年第二季度投资者及分析师电话会议。 公司将于2026年7月29日股市收盘后发布第二季度财报新闻稿，可通过官网www.corelab.com/investors查阅。本次会议将由公司董事长兼首席执行官拉里·布鲁诺、首席财务官克里斯·希尔，以及企业发展与投资者关 ...

Core Laboratories is the premier provider of reservoir characterization services. Its foundational core analysis business has been virtually untouched over the last several decades, and the firm has ...

Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...

Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EDT ...

Canopy Biosciences LLC has acquired Core Diagnostics, a provider of biomarker analysis services for biopharmaceutical researchers. No financial terms were disclosed. Canopy Biosciences is backed by ...

SRM Institute of Science and Technology (SRMIST) has signed a Memorandum of Understanding (MoU) with CORE Diagnostics, a global leader in cancer diagnostics and genomic testing. With cancer care ...

Founded in 2012, Core Diagnostics operates in Health Tech offering advanced diagnostic services focused on disease stratification and therapy selection. The company ...